Cardinal Health Inc SEC filings CAH

Cardinal Health Inc has 1,002 filings in SEC EDGAR's recent list, going back to Aug 4, 2014. Its latest annual report, Form ARS, was filed on Sep 21, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on June 30.

Cardinal Health Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
8-K Current report
Regulation FD disclosure
Oct 1, 2026 Oct 1, 2026
ARS Annual report to shareholders Sep 21, 2026 Jun 30, 2026
DEFA14A Additional proxy material Sep 21, 2026 —
DEF 14A Proxy statement Sep 21, 2026 Nov 12, 2026
4 Insider transaction Aug 20, 2026 Aug 19, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
10-K Annual report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
8-K Current report
Material agreement, Agreement ended, New debt
Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
8-K Current report
Officer or director change
Aug 5, 2026 Aug 4, 2026
11-K Employee savings plan report Jun 23, 2026 Dec 31, 2025
11-K Employee savings plan report Jun 23, 2026 Dec 31, 2025
144 Notice of proposed sale Jun 8, 2026 —
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Apr 30, 2026 Apr 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 17, 2026 Apr 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 23, 2026 Mar 17, 2026
8-K Current report
Officer or director change
Mar 5, 2026 Mar 2, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 18, 2026 Feb 15, 2026
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 10, 2026 Feb 6, 2026
144 Notice of proposed sale Feb 6, 2026 —
10-Q Quarterly report Feb 5, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 5, 2026 Feb 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
8-K Current report
Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
3 Initial insider ownership Jan 7, 2026 Dec 29, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
8-K Current report
Shareholder vote results
Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Oct 30, 2025 Oct 30, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 17, 2025 —
8-K Current report
Material agreement
Oct 10, 2025 Oct 7, 2025
8-K Current report
Material agreement
Oct 3, 2025 Sep 30, 2025
ARS Annual report to shareholders Sep 16, 2025 Jun 30, 2025
DEFA14A Additional proxy material Sep 16, 2025 —
DEF 14A Proxy statement Sep 16, 2025 Nov 5, 2025
8-K Current report
Material agreement, New debt
Aug 27, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 20, 2025 —
4 Insider transaction Aug 20, 2025 Aug 20, 2025
4 Insider transaction Aug 20, 2025 Aug 20, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
424B5 Prospectus supplement Aug 15, 2025 —
8-K Current report
Other events
Aug 14, 2025 Aug 13, 2025
FWP Free writing prospectus Aug 13, 2025 —
424B3 Prospectus Aug 13, 2025 —
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
4 Insider transaction Aug 12, 2025 Aug 12, 2025
S-3ASR Automatic shelf registration Aug 12, 2025 —
10-K Annual report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 15, 2025 —
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
11-K Employee savings plan report Jun 20, 2025 Dec 31, 2024
11-K Employee savings plan report Jun 20, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Jun 12, 2025 Jun 12, 2025
SD Specialized disclosure (conflict minerals) May 22, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 1, 2025 May 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 15, 2025 —
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
3 Initial insider ownership Mar 11, 2025 Mar 7, 2025
3 Initial insider ownership Mar 11, 2025 Mar 7, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 10, 2025 Mar 7, 2025
4 Insider transaction Feb 18, 2025 Feb 15, 2025
4 Insider transaction Feb 18, 2025 Feb 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
10-Q Quarterly report Jan 30, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 30, 2025 Jan 30, 2025
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
8-K Current report
Material agreement, New debt
Dec 9, 2024 Dec 5, 2024
4 Insider transaction Dec 3, 2024 Dec 2, 2024
4 Insider transaction Dec 3, 2024 Dec 2, 2024
4 Insider transaction Dec 3, 2024 Dec 2, 2024
4 Insider transaction Dec 3, 2024 Dec 2, 2024
8-K Current report
Material agreement, Agreement ended, New debt
Nov 22, 2024 Nov 22, 2024
4 Insider transaction Nov 18, 2024 Nov 15, 2024
8-K Current report
Other events
Nov 18, 2024 Nov 13, 2024
424B5 Prospectus supplement Nov 15, 2024 —
4 Insider transaction Nov 14, 2024 Nov 14, 2024
FWP Free writing prospectus Nov 13, 2024 —
424B3 Prospectus Nov 13, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Nov 12, 2024 Nov 11, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
S-8 POS Filing Nov 7, 2024 —
S-8 POS Filing Nov 7, 2024 —
S-8 POS Filing Nov 7, 2024 —
8-K Current report
Shareholder vote results
Nov 7, 2024 Nov 6, 2024
10-Q Quarterly report Nov 1, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 1, 2024 Nov 1, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 24, 2024 —
DEFA14A Additional proxy material Oct 23, 2024 —
8-K Current report
Material agreement, New debt
Oct 10, 2024 Oct 8, 2024
DEFA14A Additional proxy material Oct 2, 2024 —
ARS Annual report to shareholders Sep 16, 2024 Jun 30, 2024
DEFA14A Additional proxy material Sep 16, 2024 —
DEF 14A Proxy statement Sep 16, 2024 Nov 6, 2024
8-K Current report
Officer or director change
Sep 9, 2024 Sep 6, 2024
4 Insider transaction Aug 22, 2024 Aug 21, 2024
144 Notice of proposed sale Aug 21, 2024 —
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 16, 2024 —
144 Notice of proposed sale Aug 16, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
CAH (NYSE)
Fiscal year ends
June 30
Incorporated in
OH
Headquarters
Dublin, OH
SEC filer status
Large accelerated filer
SEC CIK
721371
Former names
CARDINAL HEALTH INC (until Nov 5, 2026); CARDINAL DISTRIBUTION INC (until Feb 17, 1994)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.